JNJ

167.25

+1.51%↑

NVS

115.07

+1.29%↑

ABT

127.38

+0.96%↑

TMO

462.78

-1.04%↓

ISRG

483.28

+0.46%↑

JNJ

167.25

+1.51%↑

NVS

115.07

+1.29%↑

ABT

127.38

+0.96%↑

TMO

462.78

-1.04%↓

ISRG

483.28

+0.46%↑

JNJ

167.25

+1.51%↑

NVS

115.07

+1.29%↑

ABT

127.38

+0.96%↑

TMO

462.78

-1.04%↓

ISRG

483.28

+0.46%↑

JNJ

167.25

+1.51%↑

NVS

115.07

+1.29%↑

ABT

127.38

+0.96%↑

TMO

462.78

-1.04%↓

ISRG

483.28

+0.46%↑

JNJ

167.25

+1.51%↑

NVS

115.07

+1.29%↑

ABT

127.38

+0.96%↑

TMO

462.78

-1.04%↓

ISRG

483.28

+0.46%↑

Search

Definitive Healthcare Corp

Slēgts

SektorsVeselības aprūpe

3.74 -4.1

Pārskats

Akcijas cenas izmaiņa

24h

Šī brīža

Min

3.73

Max

3.89

Galvenie mērījumi

By Trading Economics

Ienākumi

-70M

-155M

Pārdošana

-3.1M

59M

EPS

0.05

Peļņas marža

-262.021

Darbinieki

782

EBITDA

-16M

-90M

Rekomendācijas

By TipRanks

Rekomendācijas

Neitrāls

Prognoze 12 mēnešiem

+15.38% upside

Dividendes

By Dow Jones

Nākamie ieņēmumi

2025. g. 7. aug.

Tirgus statistika

By TradingEconomics

Tirgus kapitalizācija

153M

452M

Iepriekšējā atvēršanas cena

7.84

Iepriekšējā slēgšanas cena

3.74

Ziņu noskaņojums

By Acuity

100%

0%

365 / 375 Rangs Healthcare

Tehniskais rādītājs

By Trading Central

Pārliecība

Bearish Evidence

Definitive Healthcare Corp Grafiks

Pagātnes rezultāti nav uzticams nākotnes rezultātu rādītājs.

Saistītās ziņas

2025. g. 31. jūl. 23:56 UTC

Karstas akcijas

Stocks to Watch: Amazon, Bio-Rad, Coinbase, Mercer

2025. g. 31. jūl. 23:48 UTC

Tirgus saruna

Scentre Can Beat Annual Earnings Guidance -- Market Talk

2025. g. 31. jūl. 23:45 UTC

Tirgus saruna

Nikkei May Decline Amid Caution Over Earnings, Domestic Politics -- Market Talk

2025. g. 31. jūl. 23:37 UTC

Tirgus saruna

Market Talk Roundup: Latest on U.S. Politics

2025. g. 31. jūl. 23:37 UTC

Tirgus saruna

Gold Steady as Traders Eye Tariff-Deal Developments -- Market Talk

2025. g. 31. jūl. 23:12 UTC

Peļņas

OCBC: Evolving Trade, Monetary Policies, Persistent Geopolitical Tensions Expected to Weigh on Growth Prospects >O39.SG

2025. g. 31. jūl. 23:10 UTC

Peļņas

Oversea-Chinese Banking: Declining Interest-Rate Environment Weighed in Net Interest Income >O39.SG

2025. g. 31. jūl. 23:09 UTC

Peļņas

Oversea-Chinese Banking 2Q Net Interest Income S$2.28B Vs. S$2.43B >O39.SG

2025. g. 31. jūl. 23:08 UTC

Peļņas

Oversea-Chinese Banking 2Q Total Income S$3.55B Vs. S$3.63B >O39.SG

2025. g. 31. jūl. 23:08 UTC

Peļņas

Oversea-Chinese Banking 2Q Net S$1.82B Vs. Net S$1.94B >O39.SG

2025. g. 31. jūl. 23:01 UTC

Peļņas

Amazon Posts Higher Sales, Profit -- 3rd Update

2025. g. 31. jūl. 22:08 UTC

Tirgus saruna
Peļņas

Amazon CEO Impressed by Deals Signed for Project Kuiper -- Market Talk

2025. g. 31. jūl. 22:02 UTC

Tirgus saruna
Peļņas

Apple's FY Outlook Shows Sales Growth Won't Last -- Market Talk

2025. g. 31. jūl. 21:57 UTC

Tirgus saruna
Peļņas

Amazon CEO Sees Strong Early Demand for Alexa+ -- Market Talk

2025. g. 31. jūl. 21:50 UTC

Peļņas

Amazon Earnings Beat Expectations. Why the Stock Is Falling. -- Barrons.com

2025. g. 31. jūl. 21:43 UTC

Peļņas

Apple's iPhone Sales Blow Past Estimates as Customers Raced to Beat Tariffs -- 2nd Update

2025. g. 31. jūl. 21:29 UTC

Peļņas

Amazon to Invest More in Chips, Data Centers Amid Generative AI Opportunity, CFO Says

2025. g. 31. jūl. 21:26 UTC

Peļņas

Apple Expects Revenue to Grow in Mid- to High-Single Digits in Current Quarter, CFO Says

2025. g. 31. jūl. 21:26 UTC

Peļņas

MicroStrategy Beats Earnings Estimates. The Stock Rises. -- Barrons.com

2025. g. 31. jūl. 21:22 UTC

Peļņas

Amazon Has Impressive Amount of Agreements for Project Kuiper, CEO Says

2025. g. 31. jūl. 21:19 UTC

Peļņas

Apple Estimates Tariff Impact to Add $1.1B to Costs in Current Quarter, CEO Says

2025. g. 31. jūl. 21:19 UTC

Peļņas

Apple Incurred $800M in Tariff-Related Costs in 2Q, CEO Says

2025. g. 31. jūl. 21:14 UTC

Peļņas

Amazon's AWS is Seeing More Demand Than Supply, CEO Says

2025. g. 31. jūl. 21:12 UTC

Peļņas

Amazon Saw Record Prime Sign-Ups in 3 Weeks Before Prime Day, CEO Says

2025. g. 31. jūl. 21:10 UTC

Peļņas

Amazon Just Getting Started on Automation, Robotics to Boost Efficiency, CEO Says

2025. g. 31. jūl. 21:09 UTC

Peļņas

Amazon Delivered to Prime Members at Record Pace in 2Q, CEO Says

2025. g. 31. jūl. 21:09 UTC

Peļņas

Amazon CEO Sees Diversity of Sellers as Advantage for Inflation-Weary Consumers

2025. g. 31. jūl. 21:08 UTC

Peļņas

Apple iPhone Revenue Performance Driven by Popularity of iPhone 16 Family, CEO Says

2025. g. 31. jūl. 21:08 UTC

Peļņas

Amazon CEO Sees Strong Customer Adoption of Perishables Same-Day Delivery Pilot

2025. g. 31. jūl. 21:05 UTC

Peļņas

Apple's iPhone Sales Blow Past Estimates as Customers Raced to Beat Tariffs -- Update

Salīdzinājums

Cenas izmaiņa

Definitive Healthcare Corp Prognoze

Cenas mērķis

By TipRanks

15.38% augšup

Prognoze 12 mēnešiem

Vidējais 4.5 USD  15.38%

Augstākais 5 USD

Zemākais 3 USD

Pamatojoties uz 7 Volstrītas analītiķiem, kuri piedāvā 12 mēnešu cenu mērķi Definitive Healthcare Corp — pēdējo 3 mēnešu laikā.

Vērtējuma vienprātība

By TipRanks

Neitrāls

7 ratings

2

Pirkt

4

Turēt

1

Pārdot

Tehniskais rādītājs

By Trading Central

2.6467 / 2.82Atbalsts un pretestība

Īstermiņā

Bearish Evidence

Vidējā termiņā

Bearish Evidence

Ilgtermiņā

Weak Bearish Evidence

Noskaņojums

By Acuity

365 / 375 Rangs Veselības aprūpe

Ziņu noskaņojums

Ļoti spēcīga liecība "Lāču" tendencei

Volatilitāte

Zem vidējā

Ziņu apjoms (RCV)

Zem vidējā

Finanšu rādītāji

Pārdošanas un administrēšanas izmaksas

Darbības izmaksas

Peļņa pirms nodokļu nomaksas

Pārdošana

Pārdošanas maksa

Bruto peļņa no pārdošanas

Procentu izdevumi par parādu

EBITDA

Pamatdarbības peļņa

$

Par Definitive Healthcare Corp

Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution. The company's platform consists of various functional areas, such as sales, marketing, clinical research and product development, strategy, talent acquisition, and physician network management. It serves biopharmaceutical and medical device companies, healthcare information technology companies, and healthcare providers; and other diversified companies comprising staffing and commercial real estate firms, financial institutions, and other organizations in the healthcare ecosystem. Definitive Healthcare Corp. was founded in 2011 and is headquartered in Framingham, Massachusetts.